A Cross-Sectional Study to Assess Walking Performance in Subjects With Peripheral Artery and End Stage Kidney Disease
NCT ID: NCT04487301
Last Updated: 2021-10-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
36 participants
OBSERVATIONAL
2020-11-16
2021-06-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Receiving maintenance HD in a clinical setting for at least 2 weeks prior to screening
* Resting ABI \<0.90 in either leg OR Resting TBI \<0.70 in either leg
* Symptomatic as characterized by a limitation in exercise performance
Exclusion Criteria
* Chronic limb-threatening ischemia (Rutherford 4-6)
* Non-ambulatory status
* A condition other than PAD that limits ability to walk
* Open or endovascular revascularization within 3 months prior to baseline.
* Illnesses, conditions, or planned surgeries within the study period that will interfere with the interpretation of the study results
45 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sanifit Therapeutics S. A.
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alex Gold, MD
Role: STUDY_DIRECTOR
Sanifit Therapeutics
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Valley Renal Medical Group
Northridge, California, United States
Horizon Medical Research
Coral Gables, Florida, United States
Brigham and Women's Hospital
Boston, Massachusetts, United States
Boston Medical Center
Boston, Massachusetts, United States
St Louis Kidney Care
St Louis, Missouri, United States
Mountain Kidney & Hypertension Associates
Asheville, North Carolina, United States
Houston Medical Research
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SNFCT2020-07
Identifier Type: -
Identifier Source: org_study_id